Evidence map›Paper›PMID 25524056›Full record

ArticleCirculation research2015

Effects of DNA damage in smooth muscle cells in atherosclerosis.

Kelly Gray, Sheetal Kumar, Nichola Figg, James Harrison, Lauren Baker, John Mercer, Trevor Littlewood, Martin Bennett

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Circulation research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 2 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 2 syntheses or guidelines pooled it, 111 citations in OpenAlex.

  1. Pooled it
  2. Association Between Mitochondrial DNA Copy Number and Head and Neck Squamous Cell Carcinoma: A Systematic Review and Dose-Response Meta-Analysis.Medical science monitor : international medical journal of experimental and clinical research · 2021
    Pooled it
  3. Article
  4. Review
  5. Decoding Vascular Senescence: Cellular Insights and Therapeutic Strategies.International journal of biological sciences · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Kelly GrayFrom the Division of Cardiovascular Medicine (K.G., S.K., N.F., J.H., L.B., J.M., M.B.) and Department of Biochemistry (T.L.), Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.
Sheetal KumarFrom the Division of Cardiovascular Medicine (K.G., S.K., N.F., J.H., L.B., J.M., M.B.) and Department of Biochemistry (T.L.), Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.
Nichola FiggFrom the Division of Cardiovascular Medicine (K.G., S.K., N.F., J.H., L.B., J.M., M.B.) and Department of Biochemistry (T.L.), Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.
James HarrisonFrom the Division of Cardiovascular Medicine (K.G., S.K., N.F., J.H., L.B., J.M., M.B.) and Department of Biochemistry (T.L.), Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.
Lauren BakerFrom the Division of Cardiovascular Medicine (K.G., S.K., N.F., J.H., L.B., J.M., M.B.) and Department of Biochemistry (T.L.), Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.
John MercerFrom the Division of Cardiovascular Medicine (K.G., S.K., N.F., J.H., L.B., J.M., M.B.) and Department of Biochemistry (T.L.), Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.
Trevor LittlewoodFrom the Division of Cardiovascular Medicine (K.G., S.K., N.F., J.H., L.B., J.M., M.B.) and Department of Biochemistry (T.L.), Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.
Martin BennettFrom the Division of Cardiovascular Medicine (K.G., S.K., N.F., J.H., L.B., J.M., M.B.) and Department of Biochemistry (T.L.), Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom. mrb@mole.bio.cam.ac.uk.
Addenbrooke's Hospital · GB

Funding

British Heart Foundation PG/09/071British Heart Foundation PG/11/112/29272British Heart Foundation PG/11/57/29003British Heart Foundation PG/13/25/30014British Heart Foundation RG/08/009/25841British Heart Foundation RG/13/14/30314Medical Research Council G0800784Medical Research Council G1000847
6 · The paper itself

Abstract

rationaleDNA damage and the DNA damage response have been identified in human atherosclerosis, including in vascular smooth muscle cells (VSMCs). However, although double-stranded breaks (DSBs) are hypothesized to promote plaque progression and instability, in part, by promoting cell senescence, apoptosis, and inflammation, the direct effects of DSBs in VSMCs seen in atherogenesis are unknown.

objectiveTo determine the presence and effect of endogenous levels of DSBs in VSMCs on atherosclerosis. METHODS AND

resultsHuman atherosclerotic plaque VSMCs showed increased expression of multiple DNA damage response proteins in vitro and in vivo, particularly the MRE11/RAD50/NBS1 complex that senses DSB repair. Oxidative stress-induced DSBs were increased in plaque VSMCs, but DSB repair was maintained. To determine the effect of DSBs on atherosclerosis, we generated 2 novel transgenic mice lines expressing NBS1 or C-terminal deleted NBS1 only in VSMCs, and crossed them with apolipoprotein E(-/-) mice. SM22α-NBS1/apolipoprotein E(-/-) VSMCs showed enhanced DSB repair and decreased growth arrest and apoptosis, whereas SM22α-(ΔC)NBS1/apolipoprotein E(-/-) VSMCs showed reduced DSB repair and increased growth arrest and apoptosis. Accelerating or retarding DSB repair did not affect atherosclerosis extent or composition. However, VSMC DNA damage reduced relative fibrous cap areas, whereas accelerating DSB repair increased cap area and VSMC content.

conclusionsHuman atherosclerotic plaque VSMCs show increased DNA damage, including DSBs and DNA damage response activation. VSMC DNA damage has minimal effects on atherogenesis, but alters plaque phenotype inhibiting fibrous cap areas in advanced lesions. Inhibiting DNA damage in atherosclerosis may be a novel target to promote plaque stability.

Indexed as

DNA DamageAnimalsAortaAortic DiseasesApolipoproteins EBrachiocephalic TrunkCarotid ArteriesCell Cycle ProteinsCells, CulturedComet AssayDNA-Binding ProteinsDNA Breaks, Double-StrandedDNA Repair EnzymesFemaleGene Expression ProfilingHumansApolipoproteins ECell Cycle ProteinsDNA-Binding ProteinsDNA Repair EnzymesMicrofilament ProteinsMuscle ProteinsNBN protein, humanNijmegen breakage syndrome 1 protein, mouseNuclear ProteinstransgelinapoptosisatherosclerosisDNA damage

Identifiers

PMID25524056
OpenAlexW2069357463

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.